Fremond M, David C, Richez C
RMD Open. 2024; 10(3).
PMID: 39313304
PMC: 11418534.
DOI: 10.1136/rmdopen-2024-004780.
Hagen S, Henseling F, Hennesen J, Savel H, Delahaye S, Richert L
Cell Rep. 2020; 33(10):108485.
PMID: 33296655
PMC: 7833293.
DOI: 10.1016/j.celrep.2020.108485.
Gabriele L, Fragale A, Romagnoli G, Parlato S, Lapenta C, Santini S
Cytokine Growth Factor Rev. 2020; 58:66-74.
PMID: 33071044
PMC: 7543933.
DOI: 10.1016/j.cytogfr.2020.10.001.
Catalina M, Bachali P, Geraci N, Grammer A, Lipsky P
Commun Biol. 2019; 2:140.
PMID: 31044165
PMC: 6478921.
DOI: 10.1038/s42003-019-0382-x.
Yung S, Yh Yap D, Chan T
F1000Res. 2017; 6:874.
PMID: 28663794
PMC: 5473406.
DOI: 10.12688/f1000research.10445.1.
What Causes Lupus Flares?.
Fernandez D, Kirou K
Curr Rheumatol Rep. 2016; 18(3):14.
PMID: 26951252
DOI: 10.1007/s11926-016-0562-3.
SLE-associated risk factors affect DC function.
Son M, Kim S, Diamond B
Immunol Rev. 2015; 269(1):100-17.
PMID: 26683148
PMC: 4685736.
DOI: 10.1111/imr.12348.
Structural basis of the broadly neutralizing anti-interferon-α antibody rontalizumab.
Maurer B, Bosanac I, Shia S, Kwong M, Corpuz R, Vandlen R
Protein Sci. 2015; 24(9):1440-50.
PMID: 26099203
PMC: 4570538.
DOI: 10.1002/pro.2729.
Onset of Type 1 Diabetes Mellitus During Pegylated-interferon Alfa and Ribavirin Therapy for Chronic Hepatitis C Virus Infection.
Ranganathan R, Janarthanan K, Rajasekaran S
J Clin Exp Hepatol. 2015; 2(1):86-7.
PMID: 25755410
PMC: 3940551.
DOI: 10.1016/S0973-6883(12)60089-9.
Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis.
Bessone F, Poles N, Roma M
World J Hepatol. 2014; 6(6):394-409.
PMID: 25018850
PMC: 4081614.
DOI: 10.4254/wjh.v6.i6.394.
A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin.
Mistry N, Shapero J, Crawford R
Can J Gastroenterol. 2009; 23(10):677-83.
PMID: 19826642
PMC: 2776610.
DOI: 10.1155/2009/651952.
Association between IFNA genotype and the risk of systemic lupus erythematosus.
Nakashima H, Matsuno S, Akahoshi M, Miyake K, Inoue Y, Tanaka Y
Clin Rheumatol. 2005; 24(1):38-40.
PMID: 15674657
DOI: 10.1007/s10067-004-0966-8.
Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C.
Niewold T, Swedler W
Clin Rheumatol. 2004; 24(2):178-81.
PMID: 15565395
DOI: 10.1007/s10067-004-1024-2.
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.
Baechler E, Batliwalla F, Karypis G, Gaffney P, Ortmann W, Espe K
Proc Natl Acad Sci U S A. 2003; 100(5):2610-5.
PMID: 12604793
PMC: 151388.
DOI: 10.1073/pnas.0337679100.
